SCHEMBL30879488

SCHEMBL30879488

CCc1ccc(Oc2ccc(CO)cc2)cc1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LTA4H P09960 2/20 0.65
SMN1; SMN2 Q16637 3/20 0.46
CYP2C19 P33261 1/20 0.46
PPARG P37231 1/20 0.44
PPARA Q07869 1/20 0.44
MMP2 P08253 1/20 0.42
MMP3 P08254 1/20 0.42
MMP7 P09237 1/20 0.42
MMP9 P14780 1/20 0.42
MMP14 P50281 1/20 0.42
RAB9A P51151 2/20 0.42
NPC1 O15118 1/20 0.42
RXRA P19793 1/20 0.42
RXRB P28702 1/20 0.42
TRPA1 O75762 1/20 0.41
LPL P06858 1/20 0.41
LIPG Q9Y5X9 1/20 0.41
S1PR1 P21453 2/20 0.40
S1PR3 Q99500 1/20 0.40
TTR P02766 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5342317 0.88 LTA4H (0.81) LTA4HPPARGPPARAMMP2MMP3
SCHEMBL475215 0.88 SMN1; SMN2 (0.48) LTA4HSMN1; SMN2CYP2C19RAB9ANPC1
SCHEMBL8925998 0.88 SMN1; SMN2 (0.48) LTA4HSMN1; SMN2CYP2C19RAB9ANPC1
SCHEMBL92935 0.85 LPL (0.52) SMN1; SMN2TRPA1LPLLIPGALDH1A1
1,4-Butanediol SCHEMBL4599328 0.84 LTA4H (0.47) LTA4HSMN1; SMN2CYP2C19RAB9ANPC1
SCHEMBL1126411 0.82 MEN1 (0.64) LTA4HSMN1; SMN2CYP2C19RAB9ANPC1
SCHEMBL260540 0.82 LTA4H (0.65) LTA4HSMN1; SMN2PPARGPPARAMMP2
SCHEMBL8008449 0.82 LTA4H (0.65) LTA4HSMN1; SMN2ALDH1A1
SCHEMBL16933880 0.81 S1PR1 (0.46) LTA4HSMN1; SMN2CYP2C19RAB9ANPC1
SCHEMBL18637175 0.81 RXRA (0.64) LTA4HSMN1; SMN2CYP2C19RAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250346549-A2 NOVEL AROMATIC MOLECULES Xeniopro GmbH (DE) 2025-11-13 US disclosed
US-20250084023-A2 NOVEL AROMATIC MOLECULES Xeniopro GmbH (DE) 2025-03-13 US disclosed
US-20240140895-A1 NOVEL AROMATIC MOLECULES Xeniopro GmbH (DE) 2024-05-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250084023-A2 NOVEL AROMATIC MOLECULES AHR, TYR, MUSK LTA4H 3460/4885SMN1; SMN2 1224/4885CYP2C19 2098/4885
US-20250346549-A2 NOVEL AROMATIC MOLECULES AHR, TYR, MUSK LTA4H 3460/4885SMN1; SMN2 1224/4885CYP2C19 2098/4885
US-20240140895-A1 NOVEL AROMATIC MOLECULES AHR, TYR, MUSK LTA4H 3460/4885SMN1; SMN2 1224/4885CYP2C19 2098/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.